Kaplan-Meier analysis showed that osteosarcoma patients had a lower disease free survival in the high CDK11 or AR expressions group compared with patients in the low CDK11 or AR expressions group (P < 0.001 and P = 0.012) (Fig. 2E and F). Here, CDK19 is linked to osteosarcoma.